MSH Capital Advisors LLC Makes New Investment in CVS Health Co. (NYSE:CVS)

MSH Capital Advisors LLC bought a new stake in shares of CVS Health Co. (NYSE:CVS - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 4,853 shares of the pharmacy operator's stock, valued at approximately $218,000.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Norges Bank bought a new position in CVS Health in the 4th quarter worth about $839,574,000. Davis Selected Advisers grew its holdings in CVS Health by 2,998.1% in the 4th quarter. Davis Selected Advisers now owns 11,385,950 shares of the pharmacy operator's stock worth $511,115,000 after buying an additional 11,018,438 shares in the last quarter. Dodge & Cox increased its position in CVS Health by 11.2% in the 4th quarter. Dodge & Cox now owns 70,105,899 shares of the pharmacy operator's stock valued at $3,147,054,000 after acquiring an additional 7,075,209 shares during the period. Pzena Investment Management LLC boosted its position in CVS Health by 49.3% during the 4th quarter. Pzena Investment Management LLC now owns 19,610,579 shares of the pharmacy operator's stock worth $880,319,000 after acquiring an additional 6,475,271 shares during the period. Finally, Invesco Ltd. grew its stake in shares of CVS Health by 30.1% in the fourth quarter. Invesco Ltd. now owns 18,038,089 shares of the pharmacy operator's stock worth $809,730,000 after purchasing an additional 4,173,243 shares in the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

Insider Activity at CVS Health

In other CVS Health news, SVP James David Clark sold 7,513 shares of the stock in a transaction on Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total transaction of $498,487.55. Following the completion of the transaction, the senior vice president now directly owns 8,394 shares in the company, valued at $556,941.90. This represents a 47.23 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Michael F. Mahoney purchased 30,000 shares of the stock in a transaction that occurred on Tuesday, February 18th. The stock was bought at an average cost of $66.70 per share, with a total value of $2,001,000.00. Following the acquisition, the director now owns 39,356 shares of the company's stock, valued at $2,625,045.20. This represents a 320.65 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.22% of the stock is currently owned by corporate insiders.

CVS Health Stock Performance

CVS traded down $0.15 during trading on Wednesday, hitting $65.30. The stock had a trading volume of 2,962,129 shares, compared to its average volume of 11,798,055. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $71.45. The company has a 50 day simple moving average of $66.48 and a 200-day simple moving average of $58.77. The firm has a market cap of $82.33 billion, a PE ratio of 17.84, a P/E/G ratio of 0.98 and a beta of 0.57.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. Analysts expect that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd will be given a $0.665 dividend. The ex-dividend date of this dividend is Tuesday, April 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.07%. CVS Health's dividend payout ratio is currently 72.68%.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the stock. Wells Fargo & Company upped their price objective on shares of CVS Health from $68.00 to $73.00 and gave the stock an "overweight" rating in a report on Thursday, February 13th. Piper Sandler increased their price objective on shares of CVS Health from $72.00 to $74.00 and gave the company an "overweight" rating in a report on Friday, March 21st. Leerink Partnrs raised CVS Health from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, February 12th. UBS Group lowered their price target on CVS Health from $62.00 to $59.00 and set a "neutral" rating on the stock in a research report on Tuesday, February 11th. Finally, Edward Jones upgraded shares of CVS Health from a "hold" rating to a "buy" rating in a report on Thursday, January 30th. Four equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, CVS Health presently has a consensus rating of "Moderate Buy" and a consensus price target of $71.83.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.